Search Results - "Rey, Évelyne"

Refine Results
  1. 1

    Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications by Rodger, Marc A., Carrier, Marc, Le Gal, Grégoire, Martinelli, Ida, Perna, Annalisa, Rey, Évelyne, de Vries, J.I.P., Gris, Jean-Christophe

    Published in Blood (06-02-2014)
    “…A 35-year-old woman with recurrent severe placenta-mediated pregnancy complications in her 2 pregnancies asks: Will low-molecular-weight heparin help prevent…”
    Get full text
    Journal Article
  2. 2

    The use of asthma controller medications during pregnancy and the risk of gestational diabetes by Baribeau, Véronique, MSc, Beauchesne, Marie-France, MSc, Rey, Évelyne, MD, Forget, Amélie, MSc, Blais, Lucie, PhD

    Published in Journal of allergy and clinical immunology (01-12-2016)
    “…The generalized estimation equations models (Table I) indicate that the dose of ICSs among nonusers of LABAs was not significantly associated with GD…”
    Get full text
    Journal Article
  3. 3

    First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage by Bérard, Anick, Ramos, Élodie, Rey, Évelyne, Blais, Lucie, St.-André, Martin, Oraichi, Driss

    “…BACKGROUND: Conflicting findings with regard to the teratogenic risks of first trimester use of paroxetine have prompted the FDA, Health Canada, and the…”
    Get full text
    Journal Article
  4. 4

    Atrial Fibrillation in a Structurally Normal Heart during Pregnancy: A Review of Cases From a Registry and From the Literature by Sauvé, Nadine, MD, FRCPC, Rey, Évelyne, MD, MSc, FRCPC, Cumyn, Annabelle, MDCM, MHPE

    “…Abstract Objectives Atrial fibrillation (AF) in a structurally normal heart is rare during pregnancy. We wished to use our experience to expand the literature…”
    Get full text
    Journal Article
  5. 5

    Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy by Cossette, Benoit, MSc, Beauchesne, Marie-France, PharmD, Forget, Amélie, MSc, Lemière, Catherine, MD, Larivée, Pierre, MD, Rey, Évelyne, MD, Blais, Lucie, PhD

    Published in Annals of allergy, asthma, & immunology (01-05-2014)
    “…Abstract Background Recent asthma guidelines endorse the safety of long-acting β2 -agonists (LABAs) and of mild and moderate doses of inhaled corticosteroids…”
    Get full text
    Journal Article
  6. 6

    Impact of maternal use of asthma-controller therapy on perinatal outcomes by Cossette, Benoit, Forget, Amélie, Beauchesne, Marie-France, Rey, Évelyne, Lemière, Catherine, Larivée, Pierre, Battista, Marie-Claude, Blais, Lucie

    Published in Thorax (01-08-2013)
    “…Asthma during pregnancy usually requires treatment with controller medications about which more safety information is needed. The objectives are to assess the…”
    Get more information
    Journal Article
  7. 7

    Duration of antidepressant use during pregnancy and risk of major congenital malformations by Ramos, Élodie, St-André, Martin, Rey, Évelyne, Oraichi, Driss, Bérard, Anick

    Published in British journal of psychiatry (01-05-2008)
    “…Antidepressant use during the gestational period is a controversial topic. To determine whether duration of antidepressant use during the first trimester…”
    Get full text
    Journal Article
  8. 8

    Atrial fibrillation with a structurally normal heart in pregnancy: An international survey on current practice by Cumyn, Annabelle, Sauvé, Nadine, Rey, Évelyne

    Published in Obstetric medicine (01-06-2017)
    “…Background Little evidence exists for the optimal management of atrial fibrillation with a structurally normal heart in pregnancy. Methods A survey was sent to…”
    Get full text
    Journal Article
  9. 9

    Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy by Breton, Marie-Claude, MSc, Beauchesne, Marie-France, PharmD, Lemière, Catherine, MD, Rey, Évelyne, MD, MSc, Forget, Amélie, MSc, Blais, Lucie, PhD

    Published in Journal of allergy and clinical immunology (01-10-2010)
    “…Background Four studies investigating the association between inhaled corticosteroid (ICS) use during pregnancy and perinatal mortality reported no…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Determinants of the Incidence of Childhood Asthma: A Two-Stage Case-Control Study by Martel, Marie-Josée, Rey, Évelyne, Malo, Jean-Luc, Perreault, Sylvie, Beauchesne, Marie-France, Forget, Amélie, Blais, Lucie

    Published in American journal of epidemiology (15-01-2009)
    “…Extensive literature exists on potential risk factors for childhood asthma. To the authors’ knowledge, no investigators have yet attempted to disentangle the…”
    Get full text
    Journal Article
  12. 12

    Preeclampsia: Should Plasma Albumin Level Be a Criterion for Severity? by Benoit, Janie, MD, Rey, Évelyne, MD, MSc, FRCPC

    “…Abstract Objectives To determine whether plasma albumin level (ALB) is associated with preeclampsia (PE) complications and to define its role in the evaluation…”
    Get full text
    Journal Article
  13. 13

    Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study by Martel, Marie-Josée, Rey, Évelyne, Beauchesne, Marie-France, Perreault, Sylvie, Lefebvre, Geneviève, Forget, Amélie, Blais, Lucie

    Published in BMJ (29-01-2005)
    “…Abstract Objective To determine whether the use of inhaled corticosteroids during pregnancy increases the risk of pregnancy induced hypertension and…”
    Get full text
    Journal Article
  14. 14

    Systemic corticosteroids for the treatment of asthma exacerbations during and outside of pregnancy in an acute-care setting by Cossette, Benoit, Beauchesne, Marie-France, Forget, Amélie, Lemière, Catherine, Larivée, Pierre, Rey, Évelyne, Couturier, Marie, Rodrigue, Claudie, Blais, Lucie

    Published in Respiratory medicine (01-09-2014)
    “…Summary Background Asthma exacerbations are common during pregnancy with a prevalence as high as 51.9% among women with severe asthma. Objective To compare the…”
    Get full text
    Journal Article
  15. 15

    Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma by Blais, Lucie, Beauchesne, Marie-France, Rey, Évelyne, Malo, Jean-Luc, Forget, Amélie

    Published in Thorax (01-04-2007)
    “…Aim: To investigate whether the maternal use of different doses of inhaled corticosteroids (ICSs) during the first trimester of pregnancy for the treatment of…”
    Get full text
    Journal Article
  16. 16

    Maternal Asthma, its Control and Severity in Pregnancy, and the Incidence of Atopic Dermatitis and Allergic Rhinitis in the Offspring by Martel, Marie-Josée, PhD, Beauchesne, Marie-France, PharmD, Malo, Jean-Luc, MD, Rey, Évelyne, MD, MSc, Perreault, Sylvie, PhD, Forget, Amélie, MSc, Blais, Lucie, PhD

    Published in The Journal of pediatrics (01-11-2009)
    “…Objective To evaluate the relationship between maternal asthma, its level of control and severity during pregnancy, and atopic dermatitis (AD) and allergic…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Use of short-acting β2 -agonists during pregnancy and the risk of pregnancy-induced hypertension by Martel, Marie-Josée, BSc, Rey, Évelyne, MD, MSc, Beauchesne, Marie-France, PharmD, Perreault, Sylvie, PhD, Forget, Amélie, MSc, Maghni, Karim, PhD, Lefebvre, Geneviève, MSc, Blais, Lucie, PhD

    Published in Journal of allergy and clinical immunology (01-03-2007)
    “…Background The effect of inhaled short-acting β2 -agonists (SABAs) on pregnancy outcome, especially hypertensive complications, is not well documented. After…”
    Get full text
    Journal Article
  19. 19
  20. 20